Vascular actions of estrogen and Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 501-509

  Thomas, T ^a,b   Rhodin, J ^b  

^a Woodlands Med and Research Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CONJUGATED ESTROGEN; ESTROGEN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL ACTIVATION; CELL ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM LESION; ESTROGEN THERAPY; INFLAMMATION; LEUKOCYTE MIGRATION INHIBITION; MALE; MAST CELL; MENOPAUSE; NONHUMAN; RAT; THROMBOCYTE; VASCULAR AMYLOIDOSIS;

EID: 0034017960     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06406.x     Document Type: Conference Paper

References (19)

1. 1. RIPICH, D.N., S.A. PETRILL, P.J. WHITEHOUSE & E.W. ZIOL. 1995. Gender differences in language of AD patients: a longitudinal study. Neurology 45: 299-301.
2. 2. WENGER, N.K. 1998. Postmenopausal hormone therapy: is it useful for coronary prevention? Cardiol. Clin. 16: 17-25.
3. 3. GRADY, D., S.M. RUBIN, D.B. PETITTI et al. 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117: 1016-1037.
4. 4. TANG, M-X., D. JACOBS, Y. STERN et al. 1996. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348: 429-432.
5. 5. KAWAS, C., S. RESNIK, A. MORRISON et al. 1997. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 48: 1517-1521.
6. 6. HENDERSON, V.W., A. PAGANINI-HILL, C.K. EMANUEL et al. 1994. Estrogen replacement therapy in older women: comparisons between AD cases and non-demented control subjects. Arch. Neurol. 51: 896-900.
7. 7. PASIMETTI, G.M. 1996. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol. Aging 17: 707-7168.
8. 8. MCGEER, P.I., M. SCHULZER & E.G. MCGEER. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47: 425-4329.
9. 9. SELKOE, D.J. 1994. Cell biology of the amyloid β protein precursor and the mechanism of Alzheimer's disease. Ann. Rev. Cell Biol. 10: 373-403.
10. 10. THOMAS, T., G. THOMAS, C. MCLENDON et al. 1996. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380: 168-171.
11. 11. THOMAS, T., C. MCLENDON, E.T. SUTTON & G. THOMAS. 1997. Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport 8: 1387-1391.
12. 12. THOMAS, T., E.T. SUTTON, M.W. BRYANT & J.A.G. RHODIN. 1997. In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid. J. Submicrosc. Cytol. Pathol. 29: 293-304.
13. 13. IADECOLA, C., F. ZHANG, K. NIWA et al. 1999. SODI rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2: 157-1611.
14. 1-42 induce cerebrovascular endothelial dysfunction. Alzheimer's Rep. 1: 17-24.
15. 15. HOFMAN, A., A. OTT, M.M.B. BRETELER et al. 1997. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349: 151-154.
16. 16. LUSTER, A.D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
17. 17. KOH, K.K., C. CARDILLO, M.N. BUI et al. 1999. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesteremic postmenopausal women. Circulation 99: 354-360.
18. 18. GEULA, C., C-K. WU, D. SAROFF et al. 1998. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat. Med. 4: 827-831.
19. 19. XU, H., G.K. GOURAS, J.P. GREENFIELD et al. 1998. Estrogen reduces neuronal generation of Alzheimer's β-amyloid peptides. Nat. Med. 4: 447-451.